Article
Propensity-Matched Case Control Study of Anti-Interleukin-23 Therapies in Clostridioides difficile Infection
2026-07-03
Abstract excerpt
<title>Abstract</title> <p> Background <italic>Clostridioides difficile</italic> infection remains a major cause of infectious morbidity and mortality, largely driven by a dysregulated, toxin-mediated host immune response that current pathogen-targeted therapies fail to address. Interleukin-23-driven Th17 responses and subsequent neutrophil activation play a major role in disease severity and intestinal injury...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 552783b4-2faf-5be3-b63b-ea51572448de
- DOI
- 10.21203/rs.3.rs-10060050/v1
